Fund shareholders of Sutro Biopharma Inc
ISIN US8693672011 · United States · LEI 5493005U6P15VD25P851
- Fund shareholders
- 21
- Of which ETFs
- 3 18 other funds
- Value held
- 39.1M $
- Share of capital
- 9.5 % of 16.6M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 715,307 | 17.8M $ | 1.12 % | 4.31 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 533,124 | 13.3M $ | 0.00 % | 3.22 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 169,063 | 4.2M $ | 0.01 % | 1.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 43,751 | 895.6K $ | 0.00 % | 0.26 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 20,757 | 517.1K $ | 0.04 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 17,156 | 628.3K $ | 0.02 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 13,417 | 274.6K $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 11,118 | 227.6K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 10,500 | 384.5K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 9,336 | 232.6K $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 8,811 | 219.5K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 4,596 | 94.1K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 4,092 | 101.9K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 3,000 | 74.7K $ | 0.06 % | 0.02 % | as of Mar 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 1,518 | 37.8K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 1,480 | 36.9K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 770 | 19.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 466 | 17.1K $ | 0.20 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 252 | 6.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 43 | 1.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 1 | 20.5 $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.12 % | as of Mar 31, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 0.20 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.06 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.04 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.02 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.01 % | as of Mar 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 21 | +8 | 1,568,558 | +342.7 % |
| 2026Q1 | 13 | 354,321 |
Institutional managers
67 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BVF INC/IL | 1,251,788 | 31.2M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 1,069,519 | 26.6M $ | as of Mar 31, 2026 |
| SAMSARA BIOCAPITAL, LLC | 1,062,872 | 26.5M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 872,558 | 21.7M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 801,144 | 20M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 715,307 | 17.8M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 715,307 | 17.8M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 715,307 | 17.8M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 692,111 | 17.2M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 524,441 | 13.1M $ | as of Mar 31, 2026 |
| Velan Capital Investment Management LP | 512,160 | 12.8M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 465,792 | 11.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 457,441 | 11.4M $ | as of Mar 31, 2026 |
| UBS Group AG | 392,871 | 9.8M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 335,813 | 8.4K $ | as of Mar 31, 2026 |
| ACUTA CAPITAL PARTNERS, LLC | 269,425 | 6.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 232,684 | 5.8M $ | as of Mar 31, 2026 |
| KVP Capital Advisors, LP | 226,575 | 5.6M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 222,634 | 5.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 210,378 | 5.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 200,000 | 5M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 190,671 | 4.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 171,386 | 4.3M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 117,537 | 2.9M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 97,824 | 2.4M $ | as of Mar 31, 2026 |
Declared shareholders of Sutro Biopharma Inc
5 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Affinity Asset Advisors, LLC and 1 other | 6.50 % | 1,069,519 | as of Mar 31, 2026 · SCHEDULE 13G |
| Samsara BioCapital, L.P. and 4 others | 6.40 % | 1,062,872 | as of Feb 11, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 5.70 % | 946,829 | as of Apr 24, 2026 · SCHEDULE 13G |
| Perceptive Advisors LLC and 2 others | 5.40 % | 898,025 | as of Apr 14, 2026 · SCHEDULE 13G |
| Millennium Management LLC and 2 others | 1.30 % | 210,378 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Sutro Biopharma Inc". https://titelia.com/en/stocks/sutro-biopharma-inc-US8693672011